INTRODUCTION AND OBJECTIVES: Anastomotic urethroplasty is an effective but occasionally controversial treatment for short bulbar urethral strictures. Non-transecting variations of anastomotic urethroplasty were created in part to address this controversy. The objective of this study is to assess current outcomes of anastomotic urethroplasty and compare outcomes of transecting and non-transecting techniques.
METHODS: 171 patients with complete follow-up underwent anastomotic bulbar urethroplasty from September 2003 to May 2016. Patient age, stricture length, location, etiology, 90-day complications and semi-quantitative assessment of sexual dysfunction were recorded. The primary (objective) outcome was success defined as urethral patency >16Fr on routine follow-up cystoscopy. Secondary outcome measures included 90-day complications (Clavien !2) and de novo sexual dysfunction assessed at 6 months. Statistical comparison between transecting and non-transecting cohorts was made using Cox Regression Analysis and Chi-square when appropriate. RESULTS: One hundred and thirty patients underwent transecting anastomotic urethroplasty while 41 had a non-transecting anastomotic urethroplasty. Mean stricture length was 1.5AE0.5cm (range 1-3) with a mean patient age of 43.0AE18.0 years. 78.9% of patients failed prior endoscopic treatment (135/171) and 2.4% failed prior urethroplasty (4). Overall there was a 98.2% (168/171) success rate with a mean follow-up of 74.9(AE46.7) months. 7.0% (12/171) of patients experienced a 90-day postoperative complication of Clavien !2 including 2.9% wound-related complications (5), 1.8% scrotal hematomas (3), 1.8% UTI (3), and 0.6% urethral bleeding (1). 9.9% reported an adverse change in sexual function including 6.4% erectile dysfunction (11), 1.8% ejaculatory dysfunction (3), 1.2% painful erection (2), and 0.6% chordee (1). When comparing transecting and non-transecting technique success using Cox Regression analysis there was no difference in urethroplasty success (97.7% vs. 100%; p¼0.63) and no difference in postoperative complications (7.7% vs. 4.9%; p¼0.73) but patients undergoing transecting anastomotic urethroplasty were more likely to report an adverse change in sexual function (13.1%; vs. 0%; p¼0.013).
CONCLUSIONS: Anastomotic urethroplasty remains a highly effective treatment for short-segment bulbar urethral strictures with relatively minimal associated morbidity. Newer non-transecting anastomotic urethroplasty techniques appear to compare favorably in the short-term and may reduce the risk of associated sexual dysfunction. We reviewed our experience with this procedure.
METHODS: Between January 2009 and December 2015, 125 men with a mean age of 42 (range 16-77) years have undergone a "non-transecting approach" to their bulbar urethral stricture. 112 patients had idiopathic strictures, 5 had iatrogenic strictures, 5 had urethral trauma, 5 were post-radical prostatectomy strictures and 3 were post-TURP strictures. In the same timeframe, 36 transecting anastomotic urethroplasties were performed for straddle injuries and 201 dorsal patch bulbar urethroplasty were performed for long urethral strictures. 58 patients had a non-transecting mucosal anastomotic repair, 48 patients had a non-transecting augmented urethroplasty using buccal graft and 19 underwent a Heineke-Mikulicz-type stricturoplasty alone. All patients underwent clinical assessment and flow rate studies and urethrograms prospectively.
RESULTS: Clinically, 116 patients (92.8%) were happy with the result of their surgery, 2 were unhappy (but had normal flow rates) and there were 4 failures, who all underwent revisional surgery. 3 patients were lost to follow-up. The mean post-operative peak flow rate was 34.9mls per second, in 102 patients. 7 patients had flow rates of less than 15mls per second, including the 4 failures, 3 patients voided less than 100mls and where therefore not assessable and 13 patients refused a flow rate study or were lost to follow-up (n¼3). On antegrade/ retrograde urethrogram, 120 were normal, 1 had a slightly reduced calibre but had a normal flow rate, there were 4 recurrent strictures and 9 refused or were lost to follow-up (n¼3). Overall 118 of 122 patients (96%) were a success clinically by radiology and flow rate study as well as subjectively.
CONCLUSIONS: The non-transecting approach to bulbar urethroplasty gives results that are at least as good as previously reported for excision and primary anastomosis or augmented anastomotic urethroplasty or dorsal patch urethroplasty. The increasingly widespread use of this procedure is therefore entirely justified.
INTRODUCTION AND OBJECTIVES: Urethral stricture disease is seen in 2-9% of patients after transurethral resection of the prostate (TURP) but data is limited as to treatment outcomes. Our purpose is to establish patterns of disease severity and treatment for post-TURP stricture among 7 high volume centers.
METHODS: A retrospective database was created for patients who underwent management of post-TURP strictures at 7 reconstructive urology centers. Data consisted of demographics, TURP method, location/length of urethral strictures, interventions prior to urethroplasty, surgical technique used for urethroplasty, and outcomes. Exclusion criteria included age <18 and follow-up period <1 year. Success was defined as no need for intervention within the observation period. Data analysis was done from 7 institutions for a total of 130 patients.
RESULTS: Mean age was 68 years (range 41-86). 77% of patients underwent monopolar TURP (n¼100). Other modalities reported were: 10% bipolar TURP (n¼13), 3% GreenLightTM laser (n¼4), 3% holmium laser (n¼4), 2% other lasers (n¼ 3) and 5% unknown modality (n¼6). Urethral stricture locations were: 29% bulbar urethra (n¼38), 17% membranous urethra (n¼22), 11% penile urethra (n¼15), 5% fossa navicularis urethra (n¼6), and 38% multiple locations (n¼49). The average intraoperative length of strictures was 4.4cm (range 1-23cm). Average number of endoscopic interventions prior to Vol. 197, No. 4S, Supplement, Sunday, May 14, 2017 THE JOURNAL OF UROLOGY â e657 urethroplasty is 3.6 (range 0-36). Urethroplasty techniques were: anastomotic (33%, n¼43), dorsal graft (39%, n¼51), ventral graft (15%, n¼19), flap (6%, n¼8), perineal urethrostomy (2%, n¼3). 5% of patients underwent advanced reconstructive techniques such as: double graft, augmented dorsal anastomotic, Duckett, or first stage Johanson (n¼6). Overall success rate was 85% with an average time-to-failure of 23 months (range 2-151 months). Success rates for patients who had prior endoscopic intervention (urethrotomy or dilation) was 83% versus those with no prior endoscopic intervention who had a success rate of 100%, p> 0.05. Complications were reported in 17% of patients, including recurrent UTI, erectile dysfunction, urinary incontinence, and penile shortening. CONCLUSIONS: Our study represents the first multi-institutional report on the severity and management of post-TURP urethral strictures. Our data shows that the majority of post-TURP strictures are successfully managed with urethroplasty, with 85% success. Better success rates are seen in patients with no prior endoscopic intervention, suggesting early urethroplasty or referral to a reconstructive urology center is warranted.
Source of Funding: None

PD34-04 ONE-STAGE URETHROPLASTY USING DORSAL AND VENTRAL BUCCAL MUCOSAL GRAFT: LONG-TERM VALIDATED OUTCOMES
Kristi Hebert*, Martin Hofmann, Joel Gelman, Orange, CA INTRODUCTION AND OBJECTIVES: We report the short and long term results and sexual side effects of dorsal-ventral buccal graft urethroplasty (dorsal approach) for the 1 stage repair of long obliterative/near-obliterative anterior urethral strictures.
METHODS: We reviewed our prospectively maintained database. Only patients who underwent cystoscopy (4 months after surgery) and completed validated questionnaires in 2016 were included. Technical success was defined by a minimum urethral caliber of >16 French 4 months after surgery. Questionnaires included International Prostate Symptom Score (IPSS), Sexual Health Inventory for Men (SHIM), Male Sexual Health Questionnaire Ejaculatory Dysfunction Short Form (MSHQ-EjD-SF), and urethroplasty specific patient reported outcome measures (PROMs). A Wilcoxon signed-rank test was used to evaluate change in mean IPSS. RESULTS: We identified 26 patients, and 3 were excluded for lacking cystoscopy or questionnaire. Mean age at time of surgery was 54 years (19-77). Mean follow-up was 60 months (4-210). All patients had a history of prior urethral surgery or self-catheterization, 70% with multiple procedures. Ten patients (43%) had prior open urethral reconstruction, including 7 with tissue transfer. Single buccal mucosal graft was used in 30%, bilateral in 70%, and a third lower lip graft in 9%. The 4-month technical success rate was 87%. The success rates for those with and without prior open reconstruction were 90% and 85%, respectively. Two of the 3 failures (defined by urethral caliber slightly < 16 French) would be considered successfully repaired by less stringent criteria (providing a 95.6% success rate) as they required no additional procedures and were 00 very satisfied 00 with IPSS of 2 and 3. There was no significant change in mean IPSS from postoperative cystoscopy to last follow up (5.2 to 5.9, p¼0.46). In 2016, the mean SHIM and MSHQ-EjD-SF scores were 14 and 8, respectively. Regarding patient satisfaction, 74% are very satisfied, 17% are satisfied, and 9% are unsatisfied.
CONCLUSIONS: The dorsal and ventral buccal graft repair via dorsal approach, a 1-stage non-transecting technique of circumferential substitution urethroplasty, is associated with a high patient satisfaction, and validated questionnaires demonstrate lasting results. 
Source of
INTRODUCTION AND OBJECTIVES:
Multivariable assessment of independent predictors of treatment failure after ventral onlay buccal mucosal graft urethroplasty (VO-BMGU) is commonly limited by small samples sizes. Our aim was to generate a prediction model for treatment failure in a large and homogeneous contemporary population using easily available patient and surgical characteristics.
METHODS: 491 men underwent one-stage VO-BMGU at our institution between 01/2009 and 12/2015. Treatment failure was defined as any postoperative instrumentation needed. First, we compared the distribution of patient (age, BMI) and surgical characteristics (previous treatments, site of stenosis, surgical volume, length of graft, and success of voiding trial 21 days post-surgery) between patients with treatment success und treatment failure. Secondly, we performed Cox regression analyses to identify independent predictors of treatment failure. In subgroup analyses, we identified predictors of treatment failure in 406 men undergoing VO-BMGU who had never received a urethroplasty before.
RESULTS: At a median follow-up of 34.3 months (IQR 22.3-54.2 months), treatment success rates were 96.1% at three months, 92.3% at six months, 87.7% at 12 months, and 79.8% at 36 months. Overall, 98 (20%) patients suffered from treatment failure. In multivariable Cox regression analyses, age (HR¼1.01; 95% CI¼1.00-1.03; P¼0.047), second (HR¼1.02; 95% CI¼1.02-2.82; P¼0.043) and third tertile of length of graft (HR¼1.74; 95% CI¼1.03-2.94; P¼0.038), as well as failure at voiding trial 21 days after surgery (HR¼2.32; 95% CI¼1.51-3.56; P<0.001) held true as significant independent predictors of treatment failure. In multivariable subgroup analyses, failure at voiding trial 21 days after surgery (HR¼2.49; 95% CI¼1.54-4.02), length of graft above the median (>4cm; HR¼1.78; 95% CI¼1.08-2.89), and penile stenosis (HR¼2.00; 95% CI¼1.17-3.43; all P 0.022) were independent predictors of treatment failure. Previous treatment or e658 THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Sunday, May 14, 2017 
